Roche Reports Strong 2025 Performance, Lifts Outlook as Pharma Sales Drive Growth
Swiss pharmaceutical and diagnostics giant Roche Group reported a strong financial performance for full-year 2025, with group sales rising 7 % at constant exchange rates, driven by solid demand for both medicines and diagnostic solutions, the company said in a media release on Thursday.












